Advagraf + Mycophenolate Mofetil + Simulect + Corticosteroids

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Kidney Transplantation

Conditions

Kidney Transplantation

Trial Timeline

Jan 22, 2011 โ†’ May 22, 2013

About Advagraf + Mycophenolate Mofetil + Simulect + Corticosteroids

Advagraf + Mycophenolate Mofetil + Simulect + Corticosteroids is a approved stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01304836. Target conditions include Kidney Transplantation.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01304836ApprovedCompleted

Competing Products

20 competing products in Kidney Transplantation

See all competitors